Drugs / TT vaccine booster
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03848182 | Jul 2017 → Nov 2018 | malignant pancreatic neoplasm | Albert Einstein College of Medicine | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TT vaccine booster | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03848182 ↗ |
| Modality | Vaccine | “One human TT childhood vaccine booster will be administered on day 8” NCT03848182 ↗ |